Tonix Pharmaceuticals Holding Corp.

NASDAQ: TNXPHealthcare / Drug Manufacturers - Major / USA
0.470000.00Vol 117 8271Y Perf -93.64%
Sep 13th, 2019 15:58
BID0.4700 ASK0.4700
Open0.4700 Previous Close0.4700
Pre-Market- After-Trading-
 - -%  - -%
Target Price
5.77 
Analyst Rating
Strong Buy 1.00
Potencial %
1 127.66 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/100/100 
Income Ranking
 —    -
Market Cap (mil)7 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
1.05 
Earnings Date
8th Nov 2019

Today's Price Range

0.46000.4800

52wk Range

0.37009.90

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
-6.00%
1 Month
6.82%
3 Months
-70.44%
6 Months
-85.17%
1 Year
-93.64%
3 Years
-99.41%
5 Years
-99.96%
10 Years
-

Name / TickerPriceChg.Chg.%
TNXP0.47000.00000.00
AAPL218.75-4.3300-1.94
GOOG1 239.565.31000.43
MSFT137.32-0.2000-0.15
XOM72.640.66000.92
WFC48.920.27000.55
JNJ130.780.35000.27
FB187.19-0.2800-0.15
GE9.340.09000.97
JPM120.232.32001.97
Earnings HistoryEstimateReportedSurprise %
Q02 2019-0.99-0.954.04
Q01 2019-1.28-1.29-0.78
Q04 2018-3.87-6.10-57.62
Q03 2018-6.50-5.7012.31
Q02 2018-7.60-7.303.95
Q01 2018-7.00-8.80-25.71
Q04 2017-7.70-6.7012.99
Q03 2017-6.80-7.00-2.94
Earnings Per EndEstimateRevision %Trend
9/2019 QR-0.6433.33Positive
12/2019 QR-0.6334.38Positive
12/2019 FY-3.1123.21Positive
12/2020 FY-1.4944.61Positive
Next Report Date8th Nov 2019
Estimated EPS Next Report-0.64
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume117 827
Shares Outstanding (in ths.)15 717
Trades Count141
Dollar Volume31 873
Avg. Volume893 344
Avg. Weekly Volume165 665
Avg. Monthly Volume714 581
Avg. Quarterly Volume579 469
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company. The company is focused on delivering an efficacious and safe long-term treatment for PTSD. PTSD is characterized by chronic disability, inadequate treatment options, high utilization of healthcare services, and economic burden.

CEO: Seth Lederman

Teplephone: +1 212 980-9155

Address: 509 Madison Avenue, New York 10022, NY, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

56%44%

Bearish Bullish

58%42%

Bearish Bullish

54%46%

News